Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
作者信息
Szczepanski Miroslaw J, Whiteside Theresa L
机构信息
Department of Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland.
出版信息
Biomark Med. 2013 Aug;7(4):575-8. doi: 10.2217/bmm.13.68.
Abstract
摘要
相似文献
1
Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?PRAME表达升高：这对头颈鳞状细胞癌的治疗意味着什么？
Biomark Med. 2013 Aug;7(4):575-8. doi: 10.2217/bmm.13.68.
2
PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.头颈部癌症中 PRAME 的表达与预后不良的标志物相关，可能有助于在癌前病变中选择维甲酸化学预防的候选者。
Oral Oncol. 2013 Feb;49(2):144-51. doi: 10.1016/j.oraloncology.2012.08.005. Epub 2012 Sep 1.
3
Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.头颈部鳞状细胞癌的基因表达谱分析：临床观点。
Head Neck. 2010 Dec;32(12):1712-9. doi: 10.1002/hed.21491.
4
Chemoprevention in head and neck cancer.头颈部癌症的化学预防
Cancer Treat Res. 2001;106:221-35. doi: 10.1007/978-1-4615-1657-6_9.
5
Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.口腔或头颈部鳞状细胞癌中的基因畸变3：临床病理应用
Oral Oncol. 2000 Sep;36(5):404-13. doi: 10.1016/s1368-8375(00)00023-3.
6
Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.对头颈部癌症生理和分子遗传改变的治疗性利用。
Clin Cancer Res. 2003 Oct 1;9(12):4287-95.
7
Squamous Cell Carcinoma Antigen-encoding Genes as Potentially Useful Markers for the Stratification of HNSCC Tumours.鳞状细胞癌抗原编码基因作为头颈部鳞状细胞癌肿瘤分层的潜在有用标志物。
Anticancer Res. 2018 Mar;38(3):1343-1352. doi: 10.21873/anticanres.12357.
8
Aurora sheds light on head and neck squamous cell carcinoma.极光揭示了头颈部鳞状细胞癌。
Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329.
9
Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.光动力疗法对头颈部鳞状细胞癌中癌/睾丸抗原表达的影响
Anticancer Res. 2016 Aug;36(8):3973-82.
10
[The amplification of 11q13 DNA markers in squamous-cell carcinomas in the head-neck area: a correlation with the clinical course].[头颈部鳞状细胞癌中11q13 DNA标记物的扩增：与临床病程的相关性]
Strahlenther Onkol. 1998 Dec;174(12):642-3. doi: 10.1007/BF03038515.
引用本文的文献
1
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.基于 T 细胞受体的治疗：实体瘤的创新治疗方法。
J Hematol Oncol. 2021 Jun 30;14(1):102. doi: 10.1186/s13045-021-01115-0.
2
In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate.基于计算机的设计与评价：PRAME+FliCΔD2D3 作为一种新的乳腺癌疫苗候选物
Iran J Med Sci. 2021 Jan;46(1):52-60. doi: 10.30476/ijms.2019.82301.1029.
3
PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.PRAME 促进三阴性乳腺癌中的上皮间质转化。
J Transl Med. 2019 Jan 3;17(1):9. doi: 10.1186/s12967-018-1757-3.
4
Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.黑色素瘤优先表达抗原对肝细胞癌预后的影响
Gastrointest Tumors. 2017 Mar;3(3-4):128-135. doi: 10.1159/000448137. Epub 2016 Aug 3.
5
Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.黑色素瘤优先表达抗原可预防肺癌转移。
PLoS One. 2016 Jul 8;11(7):e0149640. doi: 10.1371/journal.pone.0149640. eCollection 2016.
6
Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma.鉴定黑色素瘤优先表达抗原作为肺腺癌潜在的肿瘤抑制因子。
Med Sci Monit. 2016 May 31;22:1837-42. doi: 10.12659/msm.895642.
7
Diagnostic marker signature for esophageal cancer from transcriptome analysis.基于转录组分析的食管癌诊断标志物特征
Tumour Biol. 2016 May;37(5):6349-58. doi: 10.1007/s13277-015-4400-4. Epub 2015 Dec 2.
8
The potential of tumor-derived exosomes for noninvasive cancer monitoring.肿瘤来源外泌体在无创癌症监测中的潜力。
Expert Rev Mol Diagn. 2015;15(10):1293-310. doi: 10.1586/14737159.2015.1071666. Epub 2015 Aug 2.
本文引用的文献
1
Retinoid differentiation therapy for common types of acute myeloid leukemia.维甲酸分化疗法治疗常见类型的急性髓系白血病。
Leuk Res Treatment. 2012;2012:939021. doi: 10.1155/2012/939021. Epub 2012 Jun 12.
2
PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.头颈部癌症中 PRAME 的表达与预后不良的标志物相关，可能有助于在癌前病变中选择维甲酸化学预防的候选者。
Oral Oncol. 2013 Feb;49(2):144-51. doi: 10.1016/j.oraloncology.2012.08.005. Epub 2012 Sep 1.
3
Clinical trials in chemoprevention of head and neck cancers.头颈部癌症化学预防的临床试验
Rev Recent Clin Trials. 2012 Aug;7(3):249-54. doi: 10.2174/157488712802281349.
4
Exploring biomarkers in head and neck cancer.探讨头颈部癌症的生物标志物。
Cancer. 2012 Aug 15;118(16):3882-92. doi: 10.1002/cncr.26718. Epub 2012 Jan 26.
5
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.针对 ALDH(bright) 人肿瘤起始细胞的 ALDH1A1 特异性 CD8⁺ T 细胞。
Clin Cancer Res. 2011 Oct 1;17(19):6174-84. doi: 10.1158/1078-0432.CCR-11-1111. Epub 2011 Aug 19.
6
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.具有强大抗肿瘤反应性的 PRAME 特异性同种异体 HLA 限制 T 细胞，可用于治疗性 T 细胞受体基因转移。
Clin Cancer Res. 2011 Sep 1;17(17):5615-25. doi: 10.1158/1078-0432.CCR-11-1066. Epub 2011 Jul 19.
7
8
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.抑制 PRAME 表达可导致白血病细胞周期停滞和凋亡。
Leuk Res. 2011 Sep;35(9):1219-25. doi: 10.1016/j.leukres.2011.04.005. Epub 2011 May 7.
9
Early detection of premalignant lesions and oral cancer.癌前病变和口腔癌的早期检测。
Otolaryngol Clin North Am. 2011 Feb;44(1):221-9, vii. doi: 10.1016/j.otc.2010.10.002.
10
All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.全反式维甲酸隐形脂质体防止源于肿瘤干细胞的乳腺癌复发。
J Control Release. 2011 Feb 10;149(3):281-91. doi: 10.1016/j.jconrel.2010.10.019. Epub 2010 Oct 30.
Zotero 插件